The Dual Roles of TIMP-1 in Cancer: From Protease Inhibition to Cytokine Signaling
Molecular Biology Reports · 2026
DOI: 10.1007/s11033-026-11683-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Haixia Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China. Hauptthemen laut MEDLINE: Tissue Inhibitor of Metalloproteinase-1, Neoplasms, Cytokines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province, Hubei Province Central Nervous System Repair and Functional Reconstruction Clinical Medical Research Center Open Topic Fund, Faculty Development Grants from Hubei University of Medicine.
Abstract (Originalsprache)
Tissue inhibitor of metalloproteinase-1 (TIMP-1) has emerged as a significant focus in cancer research due to its dual functionality as both an inhibitor of matrix metalloproteinases and a multifunctional cytokine. Recent studies underscore the pivotal role of TIMP-1 in extracellular matrix remodeling, a process essential for tumor progression and metastasis. Moreover, TIMP-1 performs a variety of functions within the tumor microenvironment that extend beyond its traditional protease-inhibitory role, highlighting its importance in modulating cellular processes such as proliferation, apoptosis, and immune responses. Additionally, TIMP-1 has garnered increasing attention as a prognostic biomarker and a potential therapeutic target in oncology. This review systematically compiles recent advancements in the understanding of TIMP-1's dual functions in cancer, elucidates its mechanistic roles as both a metalloproteinase inhibitor and a cytokine-like factor, and integrates its emerging significance as a biomarker and therapeutic target across diverse cancer types. By synthesizing recent findings, this study seeks to provide novel insights into the translational potential of TIMP-1 in cancer treatment, while examining its prospective implications for therapeutic strategies and clinical interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
- Department of Oncology, Hubei Provincial Clinical Research Center for central nervous system repair and functional reconstruction, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
- Key Laboratory of Cancer Therapy Resistance and Clinical Translational Study, Shiyan, Hubei, China.
- Department of Laboratory Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
- Department of Oncology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China. heavry1985@163.com.
- Key Laboratory of Cancer Therapy Resistance and Clinical Translational Study, Shiyan, Hubei, China. heavry1985@163.com.
Förderung
- Natural Science Foundation of Hubei Province
- Hubei Province Central Nervous System Repair and Functional Reconstruction Clinical Medical Research Center Open Topic Fund
- Faculty Development Grants from Hubei University of Medicine
- Hubei Provincial Clinical Research Center for Precision Diagnosis and Treatment of Liver Cancer Open Topic Fund
Zitieren
APA
Li, H., Deng, X., Wang, F., Niu, Y., Ruan, P., Gong, L., Luo, M., Luo, Z., & Cao, N. (2026). The Dual Roles of TIMP-1 in Cancer: From Protease Inhibition to Cytokine Signaling. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-11683-4
Vancouver
Li H, Deng X, Wang F, Niu Y, Ruan P, Gong L, et al. The Dual Roles of TIMP-1 in Cancer: From Protease Inhibition to Cytokine Signaling. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-11683-4
BibTeX
@article{Li2026,
author = {Li, Haixia and Deng, Xinzhou and Wang, Fang and Niu, Yanlin and Ruan, Pengfei and Gong, Li and Luo, Ming and Luo, Zhiguo and Cao, Nan},
title = {The Dual Roles of TIMP-1 in Cancer: From Protease Inhibition to Cytokine Signaling},
journal = {Molecular Biology Reports},
year = {2026},
doi = {10.1007/s11033-026-11683-4}
}
EUVIMED